The
American Journal of Gastroenterology published an alert about
potential association of a popular acne drug to development of
Inflammatory Bowel Disease.
HOUSTON, TX-The American Journal of Gastroenterology
published an important drug
alert by Laurel Prokop, President of Techstyle Group,
on September 1999 (Vol. 94, No. 9).
Ms. Prokop, a science editor and researcher for
over 15 years, reported on a self-funded study she performed which
demonstrated an association of the
popular
acne
drug
isotretinoin
(Accutane® by
Hoffman LaRoche)
with the development of gastrointestinal disease in teenagers
and young adults—Crohn's disease and ulcerative colitis.
It will remain unknown how widespread this effect
is until the FDA and the medical community undertakes an epidemiological
study of immense proportion. Laurel's Letter to the Editor was
given expedited publishing by Editor-in-Chief Eamonn Quigley
because of its importance, its originality, and its short,
lucid reporting.
Techstyle Group sponsored this effort as part of its
involvement with the medical community and advocacy for objective,
investigative research. It is a good example of uncovering and
corroborating results through detailed and clear work. Reprints of this report Letter may be obtained directly from
Elsevier Science, publisher of the Journal.
About Techstyle Group LLC
Techstyle Group LLC is a privately held company providing information
research, strategic content development, communication, and documentation
services. It specializes in using plain language
to improve the clarity of content delivered to diverse audiences
in many formats. Techstyle is a nationally certified, woman-owned
business that has operated since 1986. For
further information, visit www.Techstyle.com,
contact Techstyle Group LLC through media.tsg @ techstyle.com,
or call toll-free at 866-661-6660.
# # #
|
